Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy (Q82462509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

title

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

3

Carlos Taxonera

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22075292

17 December 2024

author name string

Natalia López-Palacios

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

Raquel Lana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

José Miguel Esteban López-Jamar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

Manuel Díaz-Rubio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

Juan L. Mendoza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22075292

17 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22075292

17 December 2024

publication date

27 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

full work available at URL

16 January 2020

https://api.elsevier.com/content/article/PII:S0953620511001415?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

https://api.elsevier.com/content/article/PII:S0953620511001415?httpAccept=text/plain

17 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

European Journal of Internal Medicine

17 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

621-625

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

16 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Clinical implications of mucosal healing for the management of IBD.

17 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Controversies in mucosal healing in ulcerative colitis

17 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

17 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

17 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Azathioprine, mucosal healing in ulcerative colitis, and the chemoprevention of colitic cancer: a clinical-practice-based forecast

17 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?

17 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis

17 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis

17 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis

17 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission

17 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

17 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Classification of inflammatory bowel disease

17 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Cortisone in ulcerative colitis; final report on a therapeutic trial.

17 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

17 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Guidelines for the management of inflammatory bowel disease in adults

17 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

17 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis

17 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Infliximab for induction and maintenance therapy for ulcerative colitis

17 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years.

17 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study.

17 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year

17 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

17 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

17 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

17 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

17 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis

17 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJIM.2011.06.017

17 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22075292 AND SRC:MED&resulttype=core&format=json

16 January 2020

1 reference